Clinical Trial Update: Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating recombinant endostatin in combination with vinorelbine and cisplatin in patients with advanced non-small cell lung cancer has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Recombinant Endostatin (endostatin)
• Vinorelbine (Vinorelbine)

Snippet

Sponsor: Jiangsu Wuzhong Pharmaceutical Group Co., Ltd. | Conditions: Advanced Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED